We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Pipeline Snagged Again As Company Pulls Diabetes Drug NDA
Sanofi Pipeline Snagged Again As Company Pulls Diabetes Drug NDA
September 13, 2013
French drugmaker Sanofi said Sept. 12 it has withdrawn its NDA for its once-daily Type 2 diabetes treatment lixisenatide, citing complications with interim cardiovascular (CV) data.